bpc-157 spinal cord injury study An iPSC-derived neural progenitor cell therapy for subacute injury: a phase 1 trial with long-term follow-up Telomerase Activity Size:10mL Meet BPC-157: often known
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26